In contrast to chronic/long-term stress that suppresses/dysregulates immune function, an acute/shortterm fight-or-flight stress response experienced during immune activation can enhance innate and adaptive immunity. Moderate ultraviolet-B (UV) exposure provides a non-invasive system for studying the naturalistic emergence, progression and regression of squamous cell carcinoma (SCC). Because SCC is an immunoresponsive cancer, we hypothesized that short-term stress experienced before UV exposure would enhance protective immunity and increase resistance to SCC. Control and short-term stress groups were treated identically except that the short-term stress group was restrained (2.5 h) before each of nine UV-exposure sessions (minimum erythemal dose, 3-times/week) during weeks 4-6 of the 10-week UV exposure protocol. Tumors were measured weekly, and tissue collected at weeks 7, 20, and 32. Chemokine and cytokine gene expression was quantified by real-time PCR, and CD4+ and CD8+ T cells by flow cytometry and immunohistochemistry. Compared to controls, the short-term stress group showed greater cutaneous T-cell attracting chemokine (CTACK)/CCL27, RANTES, IL-12, and IFN-c gene expression at weeks 7, 20, and 32, higher skin infiltrating T cell numbers (weeks 7 and 20), lower tumor incidence (weeks 11-20) and fewer tumors (weeks 11-26). These results suggest that activation of short-term stress physiology increased chemokine expression and T cell trafficking and/or function during/following UV exposure, and enhanced Type 1 cytokine-driven cell-mediated immunity that is crucial for resistance to SCC. Therefore, the physiological fight-or-flight stress response and its adjuvant-like immuno-enhancing effects, may provide a novel and important mechanism for enhancing immune system mediated tumor-detection/elimination that merits further investigation.
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Introduction
Fighting disease by augmenting endogenous biological defenses in addition to using pharmacological and surgical interventions is likely to be highly advantageous. The fight-or-flight stress response is one of nature's under-appreciated defense mechanisms that activates multiple psycho-physiological systems to promote survival. We have proposed that it is important to identify biological mechanisms by which a fight-or-flight stress response promotes survival because such mechanisms could be clinically harnessed to fight disease (Dhabhar, 2009; Dhabhar and McEwen, 2001; Dhabhar and Viswanathan, 2005) . Stress can be defined as a constellation of events that begins with a stimulus (stressor), that precipitates a reaction in the brain (stress perception), which activates physiologic fight-or-flight systems in the body (stress response) (Dhabhar and McEwen, 2001) . The idea that a stress response may be harnessed to fight disease seems counter-intuitive at first glance because numerous studies have shown that stress can suppress or dysregulate immune function (Glaser and Kiecolt-Glaser, 2005) and increase susceptibility to some forms of infection (Cohen et al., 1991) and cancer (Antoni et al., 2006; Ben-Eliyahu, 2003; Ben-Eliyahu et al., 2007 , 1991 Saul et al., 2005; Thaker et al., 2006) . However, in contrast to chronic or long-term (weeks to months in duration) stress which is generally harmful, acute or short-term (minutes-hours in duration) stress experienced at the time of immune activation or antigen exposure induces a redistribution of circulating immune cells to organs like the skin, subcutaneous tissues, and sentinel lymph nodes (Dhabhar and McEwen, 1997; Dhabhar et al., 1995b Dhabhar et al., , 1996 , increases leuko-
